accountraised through 2012, Oppenheimer said. Company is seeing higher mark-to-market gains. Outperform rating and new $20 price target. Cardinal Health (CAH) numbers increased at Goldman. CAH estimates were raised through 2012, Goldman Sachs said. Generic...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Merck, Viacom: New Targets, Estimates
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account